BioLizard announces the appointment of André van de Sande as Chairman of the Board
Ghent (Belgium), January 30, 2024 – BioLizard is pleased to announce the appointment of André van de Sande as the new Chair of our Board of Directors. As a Senior Executive with 30 years of life sciences experience and a track record in both...
BioLizard announces Swiss subsidiary and service offering for AI-powered digital transformation of life sciences at Biopôle in Lausanne
Lausanne (Switzerland) and Ghent (Belgium), 23rd January 2024 – Today we are proud to announce the incorporation of BioLizard SA and the opening of new offices at Biopôle in Lausanne, home to one of the largest biotech hubs in Switzerland. With...
Trends in single cell sequencing: Spatial transcriptomics
Spatial transcriptomics is a fast-moving and quickly growing field, although its technical complexity remains a challenge. Early adopters in industry are now beginning to explore its potential – which is why spatial transcriptomics is the third trend that we’ve...